

Wolverine (BPC-157 + TB-500) 20 MG
Premier regenerative research blend combining Body Protection Compound (BPC-157 10mg) and Thymosin Beta-4 fragment (TB-500 10mg).
Available to order
### Premier Regenerative & Angiogenic Research Blend (Wolverine)
Wolverine 20 MG [BPC-157 + TB-500 (10 MG + 10 MG)] unites Body Protection Compound-157 (stable gastric pentadecapeptide) and TB-500 (Thymosin Beta-4 active fragment) in an equimass 20 MG single-vial research blend.
Engineered for laboratories studying accelerated tissue repair mechanisms, cell motility, actin regulation, and microvascular angiogenesis.
### Research Mechanisms
• **Cellular Motility & Actin Regulation**: TB-500's role in actin filament sequestration and lamellipodia formation during cellular migration.
• **Angiogenic Signaling**: BPC-157's modulation of VEGF, VEGFR2, and early growth response 1 (EGR-1) expression.
• **Tissue Homeostasis**: Synergistic fibroblast proliferation and collagen organization in injured cell matrix models.
### Specifications
• **Active Components**: 10 MG BPC-157 + 10 MG TB-500 (20 MG Total)
• **Sequence Integrity**: BPC-157 (15 amino acids), TB-500 (Ac-SDKP sequence)
• **Purity**: ?99.0% (Reversed-Phase HPLC)
• **Solubility**: High aqueous solubility in bacteriostatic water
### Storage Instructions
• Store desiccated at -20??C.
• After reconstitution with Bacteriostatic Water, keep at 2??C-8??C. Avoid repeated freezing.
Certificate of Analysis (CoA)
Lot-specific analytical documentation verified via Reverse-Phase HPLC and Mass Spectrometry for Wolverine (BPC-157 + TB-500) 20 MG. Confirms purity, sequence identity, and laboratory-grade compliance.


